JP2012507291A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507291A5 JP2012507291A5 JP2011534635A JP2011534635A JP2012507291A5 JP 2012507291 A5 JP2012507291 A5 JP 2012507291A5 JP 2011534635 A JP2011534635 A JP 2011534635A JP 2011534635 A JP2011534635 A JP 2011534635A JP 2012507291 A5 JP2012507291 A5 JP 2012507291A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- jak2
- mutations
- polypeptide
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 28
- 102000039446 nucleic acids Human genes 0.000 claims 28
- 150000007523 nucleic acids Chemical class 0.000 claims 28
- 230000035772 mutation Effects 0.000 claims 24
- 238000000034 method Methods 0.000 claims 23
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 21
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 21
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 208000014951 hematologic disease Diseases 0.000 claims 8
- 208000018706 hematopoietic system disease Diseases 0.000 claims 8
- 208000014767 Myeloproliferative disease Diseases 0.000 claims 6
- 230000037430 deletion Effects 0.000 claims 5
- 238000012217 deletion Methods 0.000 claims 5
- 239000002773 nucleotide Substances 0.000 claims 5
- 125000003729 nucleotide group Chemical group 0.000 claims 5
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 208000032027 Essential Thrombocythemia Diseases 0.000 claims 2
- 208000017733 acquired polycythemia vera Diseases 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 238000011156 evaluation Methods 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 208000037244 polycythemia vera Diseases 0.000 claims 2
- 238000010837 poor prognosis Methods 0.000 claims 2
- 208000003476 primary myelofibrosis Diseases 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11050108P | 2008-10-31 | 2008-10-31 | |
| US61/110,501 | 2008-10-31 | ||
| US12/503,318 | 2009-07-15 | ||
| US12/503,318 US20100112571A1 (en) | 2008-10-31 | 2009-07-15 | Compositions and methods for detecting mutations in jak2 nucleic acid |
| PCT/US2009/061691 WO2010051214A1 (en) | 2008-10-31 | 2009-10-22 | Compositions and methods for detecting mutations in jak2 nucleic acid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014227524A Division JP6145083B2 (ja) | 2008-10-31 | 2014-11-07 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507291A JP2012507291A (ja) | 2012-03-29 |
| JP2012507291A5 true JP2012507291A5 (enExample) | 2012-11-29 |
| JP6017136B2 JP6017136B2 (ja) | 2016-10-26 |
Family
ID=42129212
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011534635A Active JP6017136B2 (ja) | 2008-10-31 | 2009-10-22 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
| JP2014227524A Active JP6145083B2 (ja) | 2008-10-31 | 2014-11-07 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
| JP2016229813A Pending JP2017070296A (ja) | 2008-10-31 | 2016-11-28 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014227524A Active JP6145083B2 (ja) | 2008-10-31 | 2014-11-07 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
| JP2016229813A Pending JP2017070296A (ja) | 2008-10-31 | 2016-11-28 | Ｊａｋ２核酸中の変異を検出するための組成物および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100112571A1 (enExample) |
| EP (4) | EP3093350B1 (enExample) |
| JP (3) | JP6017136B2 (enExample) |
| WO (1) | WO2010051214A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512948B2 (en) | 2008-10-31 | 2013-08-20 | Quest Diagnostics Investments Incorporated | Compositions and methods for detecting mutations in JAK2 nucleic acid |
| US20100112571A1 (en) * | 2008-10-31 | 2010-05-06 | Quest Diagnostics Investments Incorporated | Compositions and methods for detecting mutations in jak2 nucleic acid |
| WO2014068072A1 (en) * | 2012-10-31 | 2014-05-08 | Institut Gustave-Roussy | Identification, assessment and therapy of essential thrombocythemia with resistance to jak2 inhibitors |
| CN108283013B (zh) * | 2015-07-24 | 2020-10-30 | 公立大学法人名古屋市立大学 | 骨髓纤维症的诊断和预后辅助及治疗效果监测方法及装置 |
| US20220282314A1 (en) * | 2019-08-30 | 2022-09-08 | Toyo Kohan Co., Ltd. | Kit for evaluating a gene mutation related to myeloproliferative neoplasms |
| JP7456739B2 (ja) * | 2019-08-30 | 2024-03-27 | 東洋鋼鈑株式会社 | 骨髄増殖性腫瘍に関連する遺伝子変異評価用キット |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639611A (en) * | 1988-12-12 | 1997-06-17 | City Of Hope | Allele specific polymerase chain reaction |
| EP1482049A3 (en) * | 1990-11-28 | 2004-12-15 | Ludwig Institute For Cancer Research | A protein tyrosine kinase. |
| US20030092019A1 (en) * | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
| US7447594B2 (en) * | 2001-07-10 | 2008-11-04 | Ocimum Biosolutions, Inc. | Molecular cardiotoxicology modeling |
| CN1477703A (zh) * | 2002-08-02 | 2004-02-25 | ǧס������ҵ��ʽ���� | 焊球组件及其生产方法，形成焊块的方法 |
| WO2007038215A1 (en) * | 2005-09-22 | 2007-04-05 | Incyte Corporation | Tetracyclic inhibitors of janus kinases |
| US20070224598A1 (en) * | 2006-03-15 | 2007-09-27 | The Methodist Hospital Research Institute | System and method for detection of mutations in JAK2 polynucleotides |
| US20070248961A1 (en) * | 2006-04-20 | 2007-10-25 | Maher Albitar | Methods for detecting mutations in JAK2 nucleic acid |
| US20100112571A1 (en) * | 2008-10-31 | 2010-05-06 | Quest Diagnostics Investments Incorporated | Compositions and methods for detecting mutations in jak2 nucleic acid |
-
2009
- 2009-07-15 US US12/503,318 patent/US20100112571A1/en not_active Abandoned
- 2009-10-22 EP EP16158591.4A patent/EP3093350B1/en active Active
- 2009-10-22 EP EP19180822.9A patent/EP3572530B1/en active Active
- 2009-10-22 EP EP09824031.0A patent/EP2340315B1/en active Active
- 2009-10-22 JP JP2011534635A patent/JP6017136B2/ja active Active
- 2009-10-22 WO PCT/US2009/061691 patent/WO2010051214A1/en not_active Ceased
- 2009-10-22 EP EP14161006.3A patent/EP2770066B1/en active Active
-
2014
- 2014-11-07 JP JP2014227524A patent/JP6145083B2/ja active Active
-
2016
- 2016-11-28 JP JP2016229813A patent/JP2017070296A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533949A5 (enExample) | ||
| US10704092B2 (en) | Detection methods based on sequencing | |
| CN104017908B (zh) | 人乳头状瘤病毒的快速基因型鉴定分析及其装置 | |
| JP2010259438A5 (enExample) | ||
| JP2010075182A5 (enExample) | ||
| JP2012525855A5 (enExample) | ||
| JP2017501685A5 (enExample) | ||
| JP2012235778A (ja) | アセトアルデヒド脱水素酵素２及びアルコール脱水素酵素２の遺伝子変異を同時に検出する方法 | |
| JP2011515091A5 (enExample) | ||
| CA2735129A1 (en) | Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation | |
| JP2012507291A5 (enExample) | ||
| TWI248515B (en) | Array of two or more oligonucleotide primers immobilized to a solid support, and HBV variant generally in isolated form and method for identifying expression products | |
| CN103966228B (zh) | 一种Rh血型DEL型RHD93T＞A等位基因及其检测方法 | |
| JP2018512868A (ja) | 乳がんの検出のためのメタゲノムの組成物および方法 | |
| US11920188B2 (en) | Combinatorial microarray assay for clade variant detection | |
| WO2022173707A1 (en) | Combinatorial microarray assay for clade variant detection | |
| CN103937806B (zh) | 一种Rh血型DEL型RHD838G＞A等位基因及其检测方法 | |
| Yoo et al. | Diagnosis of pathogens using DNA microarray | |
| TWM467671U (zh) | 結核病快速診斷及藥效檢測結構 | |
| CN108977449B (zh) | 原发性免疫缺陷病的致病突变及其应用 | |
| TWI579722B (zh) | 藥物不良反應風險評估方法及其裝置 | |
| CN103013988A (zh) | 一种判定中国人群tnip1单核苷酸多态性与系统性红斑狼疮的关联性的方法 | |
| WO2022221605A2 (en) | Detection of sars-cov-2 variant | |
| CN107988361A (zh) | 诊断子宫颈癌或评估子宫颈癌风险的方法和试剂盒 | |
| WO2006091757A3 (en) | Detection of very virulent infectious bursal disease virus |